Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NOC vs GSK✓SelectedUSD · GSKNOC vs GSK performance historyLatest closeAs of-1.48%11/20
Stock and ETF performance explorer

NOC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+20.6%
GSK return
+53.4%
Excess return
-32.8%
Maximum drawdown
-37.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-0.1%-1.3%-1.5%
7D-2.9%-5.3%+2.4%-2.0%
30D-0.9%-3.7%+2.7%-0.3%
3M-4.8%-7.3%+2.4%-3.7%
6M-2.4%-4.2%+1.9%-1.8%
YTD-5.2%+0.9%-6.0%-5.3%
1Y-4.3%+7.3%-11.6%-5.3%
3Y+20.6%+52.7%-32.2%+6.0%
All+20.6%+53.4%-32.8%+6.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling